 |
Video: What is a Stock Split?
|
 |
Derma Sciences is a medical device company focused on two segments of the wound care marketplace: advanced wound care and traditional wound care. Co.'s products include: MEDIHONEY, which is used for the management of wounds including chronic ulcers, burns and post-operative wounds; TCC-EZ, which is an off-loading system for patients with diabetic foot ulcers; XTRASORB, which provides a line of dressings that utilizes absorbent polymer technologies; BIOGUARD, which is for prophylactic use in the prevention of hospital or community acquired infections through wound sites, especially for burns; and ALGICELL AG, an antimicrobial dressing with ionic silver as its active ingredient. According to our DSCI split history records, DSCI has had 1 split. | |
 |

DSCI (DSCI) has 1 split in our DSCI split history database. The split for DSCI took place on February 01, 2010. This was a 1 for 8 reverse split, meaning for each 8 shares of DSCI owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 125 share position following the split.
When a company such as DSCI conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the DSCI split history from start to finish, an original position size of 1000 shares would have turned into 125 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into DSCI shares, starting with a $10,000 purchase of DSCI, presented on a split-history-adjusted basis factoring in the complete DSCI split history.

Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/27/2013 |
|
End date: |
02/24/2017 |
|
Start price/share: |
$12.38 |
|
End price/share: |
$7.00 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-43.46% |
|
Average Annual Total Return: |
-13.54% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$5,655.28 |
|
Years: |
3.92 |
|
|
 |
Date |
Ratio |
02/01/2010 | 1 for 8 |
|
 |